Invention Grant
- Patent Title: Terminally modified RNA
-
Application No.: US14043927Application Date: 2013-10-02
-
Publication No.: US09597380B2Publication Date: 2017-03-21
- Inventor: Tirtha Chakraborty , Stephane Bancel , Stephen G. Hoge , Atanu Roy , Antonin de Fougerolles , Noubar B. Afeyan
- Applicant: ModernaTX, Inc.
- Applicant Address: US MA Cambridge
- Assignee: ModernaTx, Inc.
- Current Assignee: ModernaTx, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Amy E. Mandragouras, Esq.
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K48/00 ; C07H21/04 ; C12N15/67
Abstract:
The invention relates to compositions and methods for the manufacture and optimization of modified mRNA molecules via optimization of their terminal architecture.
Public/Granted literature
- US20140147454A1 TERMINALLY MODIFIED RNA Public/Granted day:2014-05-29
Information query
